E89R
TEAS SECTION 8 & 9 RECEIVED
08/06/2026
Back to search
Official data from USPTO
UROVYSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/06/2026
Trademark type
Word
Nice classes
5
Filing date
06/02/2004
Registration date
08/08/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2016
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/04/1999
First use in commerce
05/04/1999
Drawing code
4
Owner type
03
Owner location
Abbott Park, IL, US
Examiner
THOMPSON, HEATHER
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
A. L. (pessoa física)
Representatives
Megan Peccarelli ABBOTT LABORATORIES
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
medical diagnostic tests for detection of cancer in the genito-urinary tractkits composed of DNA probesreagentsantibodies for clinical medical laboratory use
Publications
History of USPTO decisions and trademark events.
43 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/27/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/27/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/22/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/22/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/22/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/22/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
08/08/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/22/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/22/2012
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/31/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/31/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/31/2011
E815
TEAS SECTION 8 & 15 RECEIVED
11/15/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
06/19/2006
ALIE
ASSIGNED TO LIE
06/09/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/02/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/18/2006
IUAF
USE AMENDMENT FILED
05/05/2006
EISU
TEAS STATEMENT OF USE RECEIVED
05/05/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/22/2005
PUBO
PUBLISHED FOR OPPOSITION
08/30/2005
NPUB
NOTICE OF PUBLICATION
08/10/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/26/2005
ALIE
ASSIGNED TO LIE
04/22/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/20/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
04/20/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2005
FAXX
FAX RECEIVED
04/19/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2005
GNRT
NON-FINAL ACTION E-MAILED
01/05/2005
CNRT
NON-FINAL ACTION WRITTEN
01/05/2005
DOCK
ASSIGNED TO EXAMINER
01/05/2005
NWAP
NEW APPLICATION ENTERED
06/08/2004
Continuous trademark protection
Get notified about every new filing that threatens UROVYSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.